The estimated Net Worth of Tom Maniatis is at least $28.4 Million dollars as of 21 March 2018. Tom Maniatis owns over 18,750 units of Acceleron Pharma Inc stock worth over $24,217,229 and over the last 11 years Tom sold XLRN stock worth over $4,197,490.
Tom has made over 5 trades of the Acceleron Pharma Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently Tom exercised 18,750 units of XLRN stock worth $95,250 on 21 March 2018.
The largest trade Tom's ever made was selling 41,000 units of Acceleron Pharma Inc stock on 30 June 2014 worth over $1,389,490. On average, Tom trades about 9,282 units every 97 days since 2013. As of 21 March 2018 Tom still owns at least 135,481 units of Acceleron Pharma Inc stock.
You can see the complete history of Tom Maniatis stock trades at the bottom of the page.
Over the last 11 years, insiders at Acceleron Pharma Inc have traded over $211,038,855 worth of Acceleron Pharma Inc stock and bought 4,435,573 units worth $172,392,007 . The most active insiders traders include Corp /De/ Celgene, Richard F Pops, and Anthony B Evnin. On average, Acceleron Pharma Inc executives and independent directors trade stock every 10 days with the average trade being worth of $7,646,210. The most recent stock trade was executed by Adam M Veness on 9 November 2021, trading 4,500 units of XLRN stock currently worth $132,165.
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.
Acceleron Pharma Inc executives and other stock owners filed with the SEC include: